Kinaset Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Kinaset Therapeutics's estimated annual revenue is currently $3.2M per year.
- Kinaset Therapeutics's estimated revenue per employee is $201,000
Employee Data
- Kinaset Therapeutics has 16 Employees.
- Kinaset Therapeutics grew their employee count by 7% last year.
Kinaset Therapeutics's People
| Name | Title | Email/Phone |
|---|
Kinaset Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $413.3M | 324 | 0% | $634M | N/A |
#2 | $47.8M | 238 | 0% | N/A | N/A |
#3 | $2.4M | 12 | -52% | N/A | N/A |
#4 | $25.7M | 128 | 39% | N/A | N/A |
#5 | $12.9M | 64 | 129% | N/A | N/A |
#6 | $23.9M | 119 | 8% | $113M | N/A |
#7 | $0.3M | 3 | 0% | N/A | N/A |
#8 | $10.3M | 51 | -14% | N/A | N/A |
#9 | $1.8M | 367 | -4% | $538M | N/A |
#10 | $50M | 249 | 3% | N/A | N/A |
What Is Kinaset Therapeutics?
At Kinaset Therapeutics, we intend to develop novel respiratory therapeutics that can positively impact people affected by intractable diseases. Our novel lead asset and experienced team combine a potentially best in class approach to treating severe asthma
keywords:N/A
N/A
Total Funding
16
Number of Employees
$3.2M
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Kinaset Therapeutics News
Kinaset Therapeutics, a developer of treatments for respiratory disorders, has raised $40 million from 5AM Ventures, Atlas Venture and Gimv. The biopharma company plans to begin Phase I and I-B clinical trials of a drug designed to treat severe asthma in the first half of next year. View round
MEDFIELD, Mass.--(BUSINESS WIRE)--Kinaset Therapeutics, Inc., a newly-founded biopharmaceutical company, today announced a $40 million Series A financing with a blue-chip investor syndicate of 5AM Ventures, Atlas Venture, and Gimv. The Company also announced an exclusive global in-license and se ...
Biotechnology startup Kinaset Therapeutics Inc. has launched with $40 million in venture financing to develop a drug that could make life easier for people with severe asthma. Asthma, a chronic disease that narrows and inflames air passages in the lungs, affects more than 339 million people glo ...
Other Companies in Boston
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.4M | 16 | -20% | N/A |
#2 | $1.4M | 16 | N/A | N/A |
#3 | $0.5M | 16 | -11% | $3.7M |
#4 | $0.5M | 16 | 0% | $8.8M |
#5 | $2.3M | 16 | N/A | N/A |